Faculty Publications
Permanent URI for this communityhttps://idr.nitk.ac.in/handle/123456789/18736
Publications by NITK Faculty
Browse
3 results
Search Results
Item Production of Naringinase by a new soil isolate of Serratia Sp.: Effect of different carbon and nitrogen sources(2013) Pavithra, M.; Belur, P.D.; Saidutta, M.B.Four strains of Naringin degrading bacteria were isolated and tested for naringinase activity. All the four isolates showed extracellular naringinase activity. The one which showed consistently good activity in three different media was selected (2 U/L) and was identified by phenotypic characterization as Serratia Sp. In shake-flask trials, effect of various carbon and nitrogen sources was studied. Among all the carbon sources, glucose enhanced the naringinase production. Peptone supplemented with ammonium nitrate was found to be favourable. Maximum of 9.2 U/L naringinase activity was achieved in the medium comprising naringin, glucose, peptone, ammonium nitrate and salts.Item Determination of specific oxygen uptake rate of Photorhabdus luminescens during submerged culture in lab scale bioreactor(2013) Belur, P.D.; Inman, F.L.; Holmes, L.D.Photorhabdus luminescens, a bacterial symbiont of entomoparasitic nematodes, was cultured in a 10 L bioreactor. Cellular density and bioluminescence were recorded and volumetric oxygen transfer coefficient (kLa) and specific oxygen transfer rates were determined during the batch process. Exponential phase of the bacterium lasted for 20 h, showing a maximum specific growth rate of 0.339 h-1 in a defined medium. Bioluminescence peaked within 21h, and was maintained until the end of the batch process (48 h). The specific oxygen uptake rate (SOUR) was high during both lag and early exponential phase, and eventually reached a stable value of 0.33 mmol g-1 h-1 during stationary phase. Maintenance of 200 rpm agitation and 1.4 volume of air per volume of medium per minute (vvm) aeration, gave rise to a kLa value of 39.5 h-1. This kLa value was sufficient to meet the oxygen demand of 14.4 g L-1 (DCW) biomass. This research is particularly relevant since there are no reports available on SOURs of symbiotic bacteria or their nematode partners. The insight gained through this study will be useful during the development of a submerged monoxenic culture of Heterorhabditis bacteriophora and its symbiotic bacterium P. luminescens in bioreactors. © 2013 © 2013 Taylor & Francis.Item Multistrain probiotic production by co-culture fermentation in a lab-scale bioreactor(Wiley-VCH Verlag info@wiley-vch.de, 2016) Jangra, M.; Belur, P.D.; Oriabinska, L.B.; Dugan, O.M.Most commercial probiotic products intended for pharmaceutical applications consist of combinations of probiotic strains and are available in various forms. The development of co-culture fermentation conditions to produce probiotics with the correct proportion of viable microorganisms would reduce multiple operations and the associated costs. The aim of this study was to develop a fermentation medium and process to achieve biomass comprising the desired proportion of two probiotic strains in co-culture. Initially, a quantification medium was developed, and the method was optimized to allow the quantification of each strain's biomass in a mixture. The specific growth rates of Lactobacillus delbrueckii spp. bulgaricus and Lactobacillus plantarum were determined in media with different carbon sources. The inoculum volume was optimized to achieve equal proportion of biomass in co-culture fermentation in test tubes. Next, fermentation was carried out in a 3-L bioreactor. A biomass concentration of 2.06 g/L, with L. delbrueckii spp. bulgaricus and L. plantarum in the ratio of 47%:53% (by weight), was achieved with concomitant production of 12.69 g/L of lactic acid in 14 h. The results show that with careful manipulation of process conditions, it is possible to achieve the desired proportion of individual strains in the final biomass produced by co-culture fermentation. This process may serve as a model to produce multistrain probiotic drugs at industrial scale. © 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.